| no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
| 1 |
A comparison of parent and provider reported influenza vaccination status of adolescents
|
Lu, Peng-jun
|
|
2012
|
30 |
22 |
p. 3278-3285
8 p.
|
article
|
| 2 |
A possible relationship of natural killer T cells with humoral immune response to 23-valent pneumococcal polysaccharide vaccine in clinical settings
|
Miyasaka, Tomomitsu
|
|
2012
|
30 |
22 |
p. 3304-3310
7 p.
|
article
|
| 3 |
Atypical forms of Guillain-Barré syndrome and H1N1-influenza vaccination
|
Shaikh, Aasef G.
|
|
2012
|
30 |
22 |
p. 3251-3254
4 p.
|
article
|
| 4 |
Charting a course for equal access to immunization
|
de Quadros, Ciro A.
|
|
2012
|
30 |
22 |
p. 3249-3250
2 p.
|
article
|
| 5 |
Economic evaluation of vaccination programme of 7-valent pneumococcal conjugate vaccine to the birth cohort in Japan
|
Hoshi, Shu-ling
|
|
2012
|
30 |
22 |
p. 3320-3328
9 p.
|
article
|
| 6 |
Editorial Board
|
|
|
2012
|
30 |
22 |
p. CO2-
1 p.
|
article
|
| 7 |
Evaluation of immune responses to a Plasmodium vivax CSP-based recombinant protein vaccine candidate in combination with second-generation adjuvants in mice
|
Lumsden, Joanne M.
|
|
2012
|
30 |
22 |
p. 3311-3319
9 p.
|
article
|
| 8 |
Immunization with recombinant Lactobacillus casei strains producing K99, K88 fimbrial protein protects mice against enterotoxigenic Escherichia coli
|
Wen, Li-Juan
|
|
2012
|
30 |
22 |
p. 3339-3349
11 p.
|
article
|
| 9 |
Killed Bacillus subtilis spores as a mucosal adjuvant for an H5N1 vaccine
|
Song, Manki
|
|
2012
|
30 |
22 |
p. 3266-3277
12 p.
|
article
|
| 10 |
Oral administration of HPV-16 L2 displayed on Lactobacillus casei induces systematic and mucosal cross-neutralizing effects in Balb/c mice
|
Yoon, Sun-Woo
|
|
2012
|
30 |
22 |
p. 3286-3294
9 p.
|
article
|
| 11 |
Repeated dose intramuscular injection of the CIMAvax-EGF vaccine in Sprague Dawley rats induces local and systemic toxicity
|
Mancebo, A.
|
|
2012
|
30 |
22 |
p. 3329-3338
10 p.
|
article
|
| 12 |
Safety and immunogenicity of a novel human Enterovirus 71 (EV71) vaccine: A randomized, placebo-controlled, double-blind, Phase I clinical trial
|
Li, Yan-Ping
|
|
2012
|
30 |
22 |
p. 3295-3303
9 p.
|
article
|
| 13 |
Safety reporting in developing country vaccine clinical trials—A systematic review
|
Muehlhans, Susann
|
|
2012
|
30 |
22 |
p. 3255-3265
11 p.
|
article
|
Journal description